|
1
|
Kwok J, O'Shea M, Hume DA and Lengeling A:
JMJD6, a JMJC dioxygenase with many interaction partners and
pleiotropic functions. Front Genet. 8:322017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang F, He L, Huangyang P, Liang J, Si W,
Yan R, Han X, Liu S, Gui B, Li W, et al: JMJD6 promotes colon
carcinogenesis through negative regulation of p53 by hydroxylation.
PLoS Biol. 12:e10018192014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Y, Long YH, Wang SQ, Zhang YY, Li YF,
Mi JS, Yu CH, Li DY, Zhang JH and Zhang XJ: JMJD6 regulates histone
H2A.X phosphorylation and promotes autophagy in triple-negative
breast cancer cells via a novel tyrosine kinase activity. Oncogene.
38:980–997. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wan J, Xu W, Zhan J, Ma J, Li X, Xie Y,
Wang J, Zhu WG, Luo J and Zhang H: PCAF-mediated acetylation of
transcriptional factor HOXB9 suppresses lung adenocarcinoma
progression by targeting oncogenic protein JMJD6. Nucleic Acids
Res. 44:10662–10675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Unoki M, Masuda A, Dohmae N, Arita K,
Yoshimatsu M, Iwai Y, Fukui Y, Ueda K, Hamamoto R, Shirakawa M, et
al: Lysyl 5-hydroxylation, a novel histone modification, by Jumonji
domain containing 6 (JMJD6). J Biol Chem. 288:6053–6062. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yi J, Shen HF, Qiu JS, Huang MF, Zhang WJ,
Ding JC, Zhu XY, Zhou Y, Fu XD and Liu W: JMJD6 and U2AF65
co-regulate alternative splicing in both JMJD6 enzymatic activity
dependent and independent manner. Nucleic Acids Res. 45:3503–3518.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee YF, Miller LD, Chan XB, Black MA, Pang
B, Ong CW, Salto-Tellez M, Liu ET and Desai KV: JMJD6 is a driver
of cellular proliferation and motility and a marker of poor
prognosis in breast cancer. Breast Cancer Res. 14:R852012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Konuma T, Yu D, Zhao C, Ju Y, Sharma R,
Ren C, Zhang Q, Zhou MM and Zeng L: Structural mechanism of the
oxygenase JMJD6 recognition by the extraterminal (ET) domain of
BRD4. Sci Rep. 7:162722017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wan J, Liu H, Yang L, Ma L, Liu J and Ming
L: JMJD6 promotes hepatocellular carcinoma carcinogenesis by
targeting CDK4. Int J Cancer. 144:2489–2500. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu X, Si W, Liu X, He L, Ren J, Yang Z,
Yang J, Li W, Liu S, Pei F, Yang X and Sun L: JMJD6 promotes
melanoma carcinogenesis through regulation of the alternative
splicing of PAK1, a key MAPK signaling component. Mol Cancer.
16:1752017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee CR, Lee SH, Rigas NK, Kim RH, Kang MK,
Park NH and Shin KH: Elevated expression of JMJD6 is associated
with oral carcinogenesis and maintains cancer stemness properties.
Carcinogenesis. 37:119–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu J, Sanborn JZ, Benz S, Szeto C, Hsu F,
Kuhn RM, Karolchik D, Archie J, Lenburg ME, Esserman LJ, et al: The
UCSC cancer genomics browser. Nat Methods. 6:239–240. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goldman M, Craft B, Swatloski T, Cline M,
Morozova O, Diekhans M, Haussler D and Zhu J: The UCSC cancer
genomics browser: Update 2015. Nucleic Acids Res. 43:D812–D817.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao M, Zhang J and Chen W and Chen W:
M1-like tumor-associated macrophages activated by
exosome-transferred THBS1 promote malignant migration in oral
squamous cell carcinoma. J Exp Clin Cancer Res. 37:1432018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lydiatt WM, Patel SG, O'Sullivan B,
Brandwein MS, Ridge JA, Migliacci JC, Loomis AM and Shah JP: Head
and neck cancers-major changes in the American Joint Committee on
cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:122–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aprelikova O, Chen K, El Touny LH,
Brignatz-Guittard C, Han J, Qiu T, Yang HH, Lee MP, Zhu M and Green
JE: The epigenetic modifier JMJD6 is amplified in mammary tumors
and cooperates with c-Myc to enhance cellular transformation, tumor
progression, and metastasis. Clin Epigenetics. 8:382016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyauchi S, Kim SS, Pang J, Gold KA,
Gutkind JS, Califano JA, Mell LK, Cohen EEW and Sharabi AB: Immune
modulation of head and neck squamous cell carcinoma and the tumor
microenvironment by conventional therapeutics. Clin Cancer Res.
25:4211–4423. 2019. View Article : Google Scholar : PubMed/NCBI
|
